The question
Does blood-vessel damage start the amyloid and tau changes of Alzheimer's disease?
This is the specific idea being tested.
The Hypothesis Critic · A guide for everyone
Vascular Hypothesis of Dementia
Does blood-vessel damage start the amyloid and tau changes of Alzheimer's disease?
What you need to knowBlood-vessel damage harms memory without establishing that it starts Alzheimer's protein changes.Relative explanatory fit: Alternative ranked ahead
Why the alternative fits better: Vascular injury and protein disease harm thinking independently or together. Improvement without changed amyloid separates these possibilities.
Review summary
Claim assessed: Cerebrovascular dysfunction, including blood–brain barrier breakdown, pericyte loss and chronic hypoperfusion, initiates the Alzheimer amyloid and tau cascades and thereby dementia.
Finding: Preregistered scope-matched SC3 gives Γ. Vascular cognitive injury reaches Ζ through convergent endogenous perturbations, inherited vasculopathies and randomized human vascular prevention. Those successes do not establish the distinguishing vascular-first AD amyloid/tau sequence. Protein-first injury, rescue without amyloid change, and opposite tau responses remain discriminators.
Key points
- SC1: Vascular risk and cerebrovascular lesions predict dementia. — HSEF Β, Moderate confidence.
- SC2: Cerebrovascular injury causes cognitive impairment. — HSEF Ζ, Moderate confidence.
- SC3: Vascular breakdown initiates AD-specific amyloid and tau cascades. — HSEF Γ, Moderate confidence.
- SC4: The Two-Hit sequence generalizes to late-life dementia. — HSEF Γ, Moderate confidence.
Verdict and review details
- Evidence grade
- HSEF Γ — Mechanistically plausible, partial system support
- Confidence
- Moderate
- Framework
- HSEF v5.3
- Review date
- Literature cutoff
- Published
- Review attribution (recorded)
- Codex
Evidence scope: 69 primary reports; literature cutoff 2026-10-07; source examination UTC date 2026-10-07; bounded critical review, not exhaustive systematic review.
The grade applies to the stated claim. Model rankings and individual subclaim grades remain separate from the overall causal-evidence grade.
Full scientific assessment and references · Scorecard (JSON) · Review source (Markdown)
The result at a glance
Blood-vessel damage harms memory without establishing that it starts Alzheimer's protein changes.
Read the labels in this illustration
THE MAIN FINDING Blood-vessel damage harms memory without establishing that it starts Alzheimer's protein changes. The idea Does blood-vessel damage start the amyloid and tau changes of Alzheimer's disease? Blood-vessel damage Amyloid & tau changes Dementia Proposed chain — plausible, not established What fits better Blood-vessel and protein damage can act separately Best fit in this review Damaged vessels Amyloid and tau damage Memory decline The separator — observed in people Memory improves amyloid unchanged What remains uncertain Whether vessel damage ever starts new amyloid or tau changes Which vessel protections prevent memory decline How the two kinds of damage combine in a given person Evidence comes from cells, animals, and people — each setting carries different weight. Vascular injury and protein disease harm thinking independently or together. Improvement without changed amyloid separates these possibilities. Conceptual illustration
Best fit in this review
Blood-vessel and protein damage can act separately
Vascular injury and protein disease harm thinking independently or together. Improvement without changed amyloid separates these possibilities.
Evidence for the stated claim
Plausible, not established
A higher rank means a better fit to the evidence in this comparison. It does not prove every part of the leading explanation.
Which explanation fits?
Another explanation fits better.
A separate question from the causal evidence grade
How does this explanation compare with alternatives?
Alternative ranked aheadThe reviewed hypothesis ranks 4 among 5 models compared; 1 alternative model(s) hold first rank for this stated claim.
Claim under review: rank 4 among 5 compared models.
Leading explanation: Parallel independent pathologies.
Position in this comparison: Between leading and last ranks.
The causal grade asks how well the stated causal claim is established. This comparison asks which of the assessed explanations fits the reviewed findings better. A leading explanation can remain unproven. Models can overlap or include the tested mechanism; an alternative ahead does not make that mechanism irrelevant. These ordinal ranks apply within this review; they do not measure the size of a difference or rank scientific strength across topics.
Read the labels in this illustration
WHY THE COMPARISON MATTERS A · The idea under review Does blood-vessel damage start the amyloid and tau changes of Alzheimer's disease? B · Leading explanation Blood-vessel and protein damage can act separately Vascular injury and protein disease harm thinking independently or together. Improvement without changed amyloid separates these possibilities. Another explanation fits better A better fit is not proof of every part of the explanation. Compatible mechanisms may overlap. Conceptual illustration Vessel damage Amyloid and tau changes (proposed consequence) Proposed sequence — not established Vessel track Protein track Each can harm thinking on its own — or both together
Idea being tested · rank 4
Does blood-vessel damage start the amyloid and tau changes of Alzheimer's disease?
Plausible, not established for the stated claim.
Best fit in this review · rank 1
Blood-vessel and protein damage can act separately
Vascular injury and protein disease harm thinking independently or together. Improvement without changed amyloid separates these possibilities.
These explanations can overlap. Ranking their fit to the evidence is separate from deciding how firmly a cause has been established.
See all the explanations compared
Rank 1: Parallel independent pathologies — Vascular lesions and proteinopathies can injure cognition independently and jointly.
Rank 2: Proteinopathy-first vascular amplification — Proteins can impair vessels, which amplify established disease.
Rank 3: Amyloid-driven vascular injury — Amyloid vasculopathy produces cerebrovascular dysfunction and injury.
Rank 4: Two-Hit vascular initiation — Vascular dysfunction starts the AD amyloid/tau cascade and dementia.
Rank 5: Shared systemic inflammatory driver — Systemic exposures produce both vascular and protein injury.
What this means
?
Plausible, not established
Blood-vessel damage harms memory without establishing that it starts Alzheimer's protein changes.
Evidence rating: Γ · Moderate confidence. How the evidence was assessed.
The important distinction
Vascular injury and protein disease harm thinking independently or together. Improvement without changed amyloid separates these possibilities.
A result about how a disease works is a separate question from whether a treatment improves health.
From an idea to an explanation
Seeing two things together does not prove one causes the other.
What is observed?
Look for the proposed factor and the outcome, in the people or systems covered by the claim.
What else explains it?
Blood-vessel and protein damage can act separately. Vascular injury and protein disease harm thinking independently or together. Improvement without changed amyloid separates these possibilities.
What test tells them apart?
Protect blood vessels before disease, testing prevention of new protein changes as well as memory decline.
What to test next
What evidence would make the answer clearer?
Read the labels in this illustration
A research question Protect blood vessels before disease, testing prevention of new protein changes as well as memory decline. 1 · Change the proposed cause Proposed test Control Protect blood vessels before disease No vessel protection 2 · Measure the relevant outcome Proposed test Control Measure new amyloid and tau changes, and memory decline Same measures in control 3 · Check the result independently Proposed test Control An independent team repeats the same setup Compare test and control Conceptual illustration
A useful next question
Protect blood vessels before disease, testing prevention of new protein changes as well as memory decline.
Change the proposed cause
Check that the intended change really happened.
Measure the relevant outcome
Allow for other factors and compare with suitable controls.
Check whether it holds up
Look for independent confirmation and the limits of the effect.
These are questions for research, not a claim that the proposed studies have already succeeded.
Read the scientific study designs
Proposed tests: 1 test design(s) are registered in the scorecard.
In plain terms, researchers would change the proposed cause, check that it changed as intended, then measure a meaningful outcome while controlling plausible alternatives. The result should be able to support or count against the claim—not only show that a pathway exists.
Experiment 1: Registered boundary experiment
Study design: Enroll baseline vascular-risk and molecularly amyloid/tau-negative strata, then selectively correct the implicated endothelial/pericyte lesion with verified brain engagement. Combine with orthogonal protein-directed comparison and a non-APP-initiated endogenous model using mediator reinstatement. Follow new biomarker conversion, adjudicated disease and cognitive trajectory, with independent replication.
What would be measured: Incident amyloid/tau conversion, neuronal/white-matter integrity, dementia subtype and sustained cognition
Important controls: Baseline genotype/proteins, age, stroke, vascular lesion, BBB assay specificity, general hemodynamics, bundled care, mortality and attrition
Result that would support the claim: Engaged vascular preservation prevents new AD-specific proteins and disease, and matched lesion reinstatement reverses that protection in predicted strata
Result that would count against it: Adequate early vascular correction preserves cognition without changing protein onset, or protein-directed correction prevents vascular injury instead
Explore the evidence
Read the complete scientific review.
Follow the studies, detailed comparisons and evidence ratings behind this guide.
Open the scientific review →